Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Whilst the market is currently led by Novo Nordisks semaglutide (Ozempic/Wegovy) and Eli Lillys tirzepatide (Mounjaro/Zepbound), stronger competition is expected with new entrants (Boehringer Ingelheim, Amgen, Pfizer, Roche amongst others) offering novel mechanisms (dual agonists, triple agonists and amylins), formulations (oral vs injectable) and dosing regimens (daily vs weekly vs monthly).
Some individuals may experience side effects such as nausea, diarrhea, or abdominal pain, especially soon after starting semaglutide
Table 5: Type 2 Diabetes Mellitus Adult Patient Information for Toujeo TOUJEO (Too-Jay-o) (insulin glargine injection) 300 units/mL (U-300) for subcutaneous use Do not share your TOUJEO SoloStar or TOUJEO Max SoloStar pen with other people, even if the needle has been changed
.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)
Never adjust your dose without consulting your prescriber
US$ 24.07
US$ 25.51
US$ 20.35
